Navigation Links
Bio-Optronics Incorporates RxPaying(TM) Patient Stipend Debit Card Feature in Clinical Conductor(TM) Clinical Trial Management System (CTMS)

ROCHESTER, N.Y., April 21 /PRNewswire/ -- Bio-Optronics, Inc. will enhance its Clinical Conductor(TM) Clinical Trial Management System with click-through integration to Interspond's RxPaying(TM) debit card solution. This offers a patient stipend payment alternative which improves efficiency and increases patient satisfaction. Clinical Conductor(TM) CTMS provides natural points in clinical trial workflow into which best-in-class tools and expertise can be integrated seamlessly. Dan Kerpelman, President and CEO states, "We are pleased to be integrating RxPaying(TM) debit cards as an efficient alternative to the patient stipend payment process and will continue to leverage Clinical Conductor(TM) as the entry point for seamless integration to tools that optimize efficiency, productivity, and improve collaboration across the clinical environment."

Clinical Conductor(TM) CTMS, proven to improve site efficiency and productivity, handles the complete enterprise workflow, from business development, to patient databases, recruitment, scheduling, workload planning, finances, and complete oversight and reporting, and provides an innovative Electronic Data Capture option. The academic medical center clinical trial management system solution adds research administration capabilities and custom interfaces to hospital enterprise systems.

The Rx Paying(TM) Debit Card helps ensure higher patient participation and retention by providing immediate access to their funds, which can be used to purchase items, request cash back from a purchase or get cash from an ATM. It centralizes the process of patient reimbursement for clinical studies as a whole. "Integrating RxPaying(TM) with Clinical Conductor(TM), one of the leading CTMS in the industry, is a natural fit and we are excited about our partnership. While both products are excellent stand-alone systems, the integration creates a more dynamic product by eliminating redundancy and streamlining the reimbursement process," according to Kathy S. Cox, President & CEO of Interspond.

Bio-Optronics, Inc. develops, deploys, and operates software products and custom information technology solutions to help healthcare professionals manage and optimize workflow, thus enhancing quality, productivity, and patient and staff satisfaction. For over 20 years, Bio-Optronics has demonstrated leadership in innovation, expertise in workflow and integration, and a singular approach to unparalleled customer service. Our workflow solutions are used in over 30 Veterans' Administration and other hospitals in the U.S., and over 400 clinical research sites around the world.

Interspond is a Trial Management Organization (TMO) for the pharmaceutical and biotechnology industries working to identify study opportunities for sites' participation. We maintain a database of hundreds of qualified, experienced investigative sites capable of conducting Phase I through Phase IV studies. These sites are located throughout the country and are multi-therapeutic in nature. Our RxPaying(TM) service offers electronic reimbursement for the clinical research industry. RxPaying(TM) streamlines and simplifies the process of reimbursing patients for participation in clinical research studies through the use of an instant issue debit card.

CONTACT: Bio-Optronics, (877) 279-8377,; Maria Durkin, VP, Director Marketing and Operations,

SOURCE Bio-Optronics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife
2. ASA plus clopidogrel reduces heart attack risk in patients with acute coronary syndrome
3. First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
4. Surveyed Specialists Foresee Greater Use of Parenteral Outpatient Therapy for the Treatment of Osteomyelitis
5. WakeMed Shares Best Practices for Tracking Assets, Patients
6. Tragic choices: Is it better for doctors or patient families to decide?
7. Thomson Reuters Study Finds More Patients Postponing Medical Care Due to Cost
8. Genetic variants predict recurrence of bladder cancer, patient survival
9. Acupuncture eases radiation-induced dry mouth in cancer patients
10. Doctor-Patient Talks Key to Blacks Getting Cancer Screens
11. PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap and ... and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s Santa ... and Sepsis conditions present in similar ways and require time-critical intervention to avoid large ...
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... Mass. (PRWEB) , ... November 26, 2015 , ... ... thorough second medical opinion process, participated in the 61st annual Employee Benefits Conference. ... Plans and took place Sunday, November 8th through Wednesday, November 11th, 2015. The ...
(Date:11/25/2015)... ... 25, 2015 , ... As part of a global movement ... volunteers together who want to combine talents and resources to help create sustainable ... process. The non-profit launched its first major fundraiser on November 6, 2015 at ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the ... loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and ... hair, without the need for surgery, prescription pills, or topical foams. , “Capillus272™ ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  The American ... and Gynecologists (ACOG), and the March of Dimes ... Protecting Our Infants Act of 2015 ... number of newborns born exposed to drugs, such ... the bill,s introduction, all three organizations have worked ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
Breaking Medicine Technology: